Your browser doesn't support javascript.
loading
Reporting of RT-PCR cycle threshold (Ct) values during the first wave of COVID-19 in Qatar improved result interpretation in clinical and public health settings.
Coyle, Peter V; Al Molawi, Naema Hassan; Kacem, Mohamed Ali Ben Hadj; El Kahlout, Reham Awni; Al Kuwari, Einas; Al Khal, Abdullatif; Gillani, Imtiaz; Jeremijenko, Andrew; Saeb, Hatoun; Al Thani, Mohammad; Bertollini, Roberto; Abdul Rahim, Hanan F; Chemaitelly, Hiam; Tang, Patrick; Latif, Ali Nizar; Al Kaabi, Saad; Al Maslamani, Muna A Rahman S; Morris, Brendan David; Al-Ansari, Nasser; Kaleeckal, Anvar Hassan; Abu Raddad, Laith J.
Afiliação
  • Coyle PV; Hamad Medical Corporation, Doha, Qatar.
  • Al Molawi NH; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Kacem MABH; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, UK.
  • El Kahlout RA; Hamad Medical Corporation, Doha, Qatar.
  • Al Kuwari E; Hamad Medical Corporation, Doha, Qatar.
  • Al Khal A; Hamad Medical Corporation, Doha, Qatar.
  • Gillani I; Hamad Medical Corporation, Doha, Qatar.
  • Jeremijenko A; Hamad Medical Corporation, Doha, Qatar.
  • Saeb H; Hamad Medical Corporation, Doha, Qatar.
  • Al Thani M; Hamad Medical Corporation, Doha, Qatar.
  • Bertollini R; Ministry of Public Health, Doha, Qatar.
  • Abdul Rahim HF; Ministry of Public Health, Doha, Qatar.
  • Chemaitelly H; Ministry of Public Health, Doha, Qatar.
  • Tang P; College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
  • Latif AN; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Al Kaabi S; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
  • Al Maslamani MARS; Sidra Medicine, Doha, Qatar.
  • Morris BD; Hamad Medical Corporation, Doha, Qatar.
  • Al-Ansari N; Hamad Medical Corporation, Doha, Qatar.
  • Kaleeckal AH; Hamad Medical Corporation, Doha, Qatar.
  • Abu Raddad LJ; Present address: Hamad Medical Corporation, Doha, Qatar.
J Med Microbiol ; 71(5)2022 May.
Article em En | MEDLINE | ID: mdl-35576147

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article